MMJ Labs, LLC
Publicly observedAtlanta, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Atlanta | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | MMJ Labs, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | MRK1VCY9DMB6 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Sept 2023Publicly observed
NIH SBIR/STTR award: Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
USD 347,237.00 · National Institute on Drug Abuse · Source: NIH RePORTER (opens in a new tab)
- Grant1 Sept 2023Publicly observed
NIH SBIR/STTR award: Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
USD 455,972.00 · National Institute on Drug Abuse · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.